General News

Breaking News

Liberia to benefit from Ebola Vaccine

jJoseph Koon/Maximilian Kasseh

MONROVIA, LIBERIA-Liberia stands to benefit from the world’s approved Ebola Vaccine in Europe after more than two decades of research.

The Merck’s Vaccine known as Ervebo was approved by the European Medicines Agency to be licensed.

The approved Ebola Vaccine is also a major boost for Liberia, one of the hard hit Ebola nations in West Africa in 2014, through intense International Community’s effort.

According to the European Commission official in charge of health and food safety, Vytenis Andriukaitis, the approved world’s Ebola Vaccine is a major step forward in saving lives in Liberia, Africa and beyond.

According to research, the vaccine has been used only in clinical trial.

Meanwhile, the Food and Drug Administration is reviewing Merck’s Submission for approval in the United States and is expected to make a decision sometime before March 2020.

The Vaccine was designed at Canada’s National Microbiology Laboratory, with funding from the United States Government Biomedical Advanced Research and Development Authority.

It was originally licensed to NewLink Genetics (NLNK),a small biotech company, which did little to advance it.


Copyright 2012 All Rights Reserved.